QVT Financial LP filed a Form 4 with the SEC on November 18, 2026, reporting open-market sales and in-kind distributions of Roivant Sciences Ltd. common shares on November 16 and 17, 2026.
Key Highlights
- Open-market sales on November 16: QVT Financial LP disposed of 79,461 shares at $39.17 and 18,927 shares at $38.99 from QVT Financial Investment Cayman Ltd., and 550,280 shares at $39.17 and 131,073 shares at $38.99 from QVT P&E Roiv Hldgs Ltd.
- In-kind distributions on November 17: QVT P&E Roiv Hldgs Ltd., QVT DCH, and QVT FIC each made a pro rata in-kind distribution for no consideration, involving 385,620, 2,635,169, and 15,969 shares respectively.
- Additional sales on November 17: 75,716 shares were sold at $38.24 from QVT FIC, 525,507 shares at $38.24 from QVT P&E Roiv Hldgs Ltd., and 798 shares at $38.24 from QVT Deferred Compensation Holdings Ltd.
- Post-transaction holdings: QVT Financial LP reported aggregate beneficial ownership of 19,304,554 common shares following all reported transactions, held through QVT DCH and QVT FIC.
- QVT P&E Roiv Hldgs Ltd. reduced to zero: Following the November 17 sales and distributions, QVT P&E Roiv Hldgs Ltd. held 0 common shares.
- Relationship to issuer: QVT Financial LP is listed as "Director by Deputization" in the filing.
QVT Financial LP's Multi-Day Share Reduction in Roivant Sciences
According to the Form 4 filed on November 18, 2026, QVT Financial LP, a Delaware limited partnership, reported a series of dispositions of common shares in Roivant Sciences Ltd. (NASDAQ:ROIV) across two trading days. On November 16, 2026, shares held through two affiliated entities were sold in open-market transactions: QVT Financial Investment Cayman Ltd. sold 79,461 shares at $39.17 and 18,927 shares at $38.99, while QVT P&E Roiv Hldgs Ltd. sold 550,280 shares at $39.17 and 131,073 shares at $38.99.
On November 17, 2026, the filing disclosed a separate category of transactions coded "J," described in the footnotes as in-kind distributions made on a pro rata basis for no consideration. QVT P&E Roiv Hldgs Ltd. distributed 385,620 shares, QVT Deferred Compensation Holdings Ltd. distributed 2,635,169 shares, and QVT Financial Investment Cayman Ltd. distributed 15,969 shares. The filing states these were made "for no consideration." Following those distributions, additional open-market sales occurred on the same date: 75,716 shares from QVT FIC, 525,507 shares from QVT P&E, and 798 shares from QVT DCH, all at $38.24.
The filing states that after all reported transactions, QVT Financial LP "may be deemed to be the beneficial owner of 19,304,554 Common Shares," consisting of shares held by QVT DCH and QVT FIC. The filing further notes that QVT Financial GP LLC, as general partner of QVT, "may be deemed to beneficially own the same number of Common Shares reported by QVT." QVT disclaims beneficial ownership of the reported shares "except to the extent of any pecuniary interest therein," according to the filing.
What Was Disclosed
QVT Financial LP disclosed open-market sales and in-kind pro rata distributions of Roivant Sciences common shares on November 16 and 17, 2026, across three affiliated holding entities, resulting in aggregate reported beneficial ownership of 19,304,554 common shares.



Please wait processing your request...